tiprankstipranks
Oxford BioMedica plc (GB:OXB)
LSE:OXB
UK Market
OXB
Oxford BioMedica
RESEARCH TOOLSreports

Oxford BioMedica (OXB) Income Statement

111 Followers

Oxford BioMedica Income Statement

Last quarter (Q4 2025), Oxford BioMedica's total revenue was £95.52M, an increase of 105.51% from the same quarter last year. In Q4, Oxford BioMedica's net income was £-3.77M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 168.74M£ 128.80M£ 89.54M£ 139.99M£ 142.80M
Gross Profit
£ 65.98M£ 53.02M£ 39.73M£ 69.18M£ 82.64M
Operating Expenses
£ 99.52M£ 92.40M£ 223.90M£ 120.74M£ 61.71M
Depreciation and Amortization
£ 0.00£ 23.09M£ 28.71M£ 26.43M£ 12.46M
EBITDA
£ -33.54M£ -14.33M£ -148.62M£ -10.80M£ 33.22M
Operating Income
£ -33.54M£ -39.38M£ -184.17M£ -30.22M£ 20.77M
Other Income/Expenses
£ 1.61M£ -7.89M£ -4.35M£ -15.76M£ -888.00K
Pretax Income
£ -31.94M£ -47.27M£ -188.53M£ -45.98M£ 19.88M
Net Income
£ -30.13M£ -43.19M£ -157.49M£ -39.16M£ 19.01M
Per Share Metrics
Basic EPS
£ -0.27£ -0.42£ -1.63£ -0.41£ 0.23
Diluted EPS
£ -0.27£ -0.42£ -1.63£ -0.41£ 0.22
Weighted Average Shares Outstanding
 111.92M 103.46M 96.56M 94.83M 83.48M
Weighted Average Shares Outstanding (Diluted)
 111.92M 103.46M 96.56M 94.83M 85.62M
Currency in GBP

Oxford BioMedica Earnings and Revenue History